Hadley Harbor Master Investors (Cayman) L.P. Crispr Therapeutics Ag (CRSP) insider trading activity
Hadley Harbor Master Investors (Cayman) L.P. is > 10% Shareholder of CRISPR Therapeutics AG. Currently has a direct ownership of 744,380 shares of CRSP, which is worth approximately $35.6 Million. The most recent transaction as insider was on Oct 24, 2016, when has been sold 744,380 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
744K
0%
3M change
0%
12M change
Total Value Held
$35.6 Million
HHM
Hadley Harbor Master Investors (Cayman) L.P.
> 10% Shareholder
Boston, MA